Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.
Also called NCT05760456
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 140 participants
- Sponsor
- Centre of Clinical Pharmacology, Hanoi Medical University
- Registry
-
NCT05760456
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Vietnam
- Registry status
- Unknown status
Technical summary
Registry record NCT05760456. Randomized; no masking; primary purpose treatment. Start 2023-03-15 (anticipated); primary completion 2024-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of DIDALA Monotherapy in Patients With Type 2 Diabetes Compared With Metformin.
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- DIDALA hard capsules
- Intervention (Drug)
- Metformin
- Lead sponsor
- Centre of Clinical Pharmacology, Hanoi Medical University
Record details
- Record id
cardio:ct-nct05760456- Content hash
39ce1e5a72559a6b498a5f449eb66fc89b35a53cd44bb2baa1e21e0da53274cb